Charles Russell Speechlys advises Emergex Vaccines on $11m fundraising
Charles Russell Speechlys has advised longstanding client Emergex Vaccines Holding Limited on their recent $11m equity fundraising to advance its vaccine development programme for infectious diseases.
Emergex is a UK-based biotechnology company and pioneers of developing synthetic ‘set point’ vaccines against health threats such as COVID-19, Dengue Fever, Zika, Ebola, pandemic flu and serious intra-cellular bacterial infections.
This was a follow-on round with new and existing investors after Emergex raised over $11m earlier this year in a Series A round led by a Singaporean venture capital investor, which we also advised on. Alongside this transaction, we continue to advise on Emergex’s UK and international research and development collaborations and ventures (including a Brazilian collaboration and the launch of its US subsidiary by acquisition of a US research lab).
Storme Moore-Thornicroft, co-founder and COO of Emergex, commented: “This funding round demonstrates our investors’ continuing confidence in Emergex’s unique technology in creating safe, effective vaccines that can be rapidly developed and deployed against a range of infectious diseases. Many thanks to Will and the Charles Russell Speechlys team for their instrumental advice, both from a transactional and advisory perspective.”
Will Nash commented: “We are delighted to have supported Emergex through their recent fundraising rounds which will facilitate their exciting and innovative work on deploying new technologies to develop vaccines against some of the world’s most immediate heath threats.”
The Future of Property Careers
Join to our panel discussion and Q&A with industry leaders on the range of opportunities within the property and construction sector.
Q&A: Talking the telecoms talk
Georgina Muskett and Jonathan Wills answer queries on Electronic Communications Code agreement.
Property Patter: Navigating the complexities of Pharmacy Property
Pharmacy property is a specialist area which contains many traps for the unwary.
COVID-19 Vaccination – can an employer make it compulsory for employees?
We review what legal issues to take into account when considering to make vaccination compulsory as an employer.
The Lawyer, New Law Journal, International Adviser, CDR Magazine and eprivateclient report on the firm's partner promotions
Charles Russell Speechlys promoted five lawyers to partner, effective 1 May 2021.
Linking ESG and Executive Pay
How does a business go about embedding a focus on strong ESG performance into the structures and culture of its organisation?
National Security and Investment Act granted Royal Assent
The Act establishes a new regime for the review of mergers, acquisitions and other transactions that could threaten national security.
Recent Trends In Firewall Legislation: BVI, Bermuda And Gibraltar
Charles Russell Speechlys advises Waverton on acquisition of Cornerstone Asset Management
Established in July 2010 and with offices in Edinburgh and Glasgow, Cornerstone offers wealth management and financial planning advice.
What do the new Debt Respite Scheme Regulations mean for Landlords and Tenants?
This will provide legal protection from creditors in the form of either a breathing space or a mental health crisis moratorium.
Charles Russell Speechlys promotes five to Partner
The promotions are effective 1 May 2021 and are accompanied by one Legal Director and 15 Senior Associate promotions.
Risk allocation in commercial leases: the High Court considers rent suspension, insurance and frustration arguments
Read our summary of the full judgement on the latest Covid arrears case.
Charles Russell Speechlys boosts private wealth offering with the hire of an international tax team
Robert Reymond will be joined at the firm by Leigh Nicoll, Emma Tyrrell and Oliver Cooper.
Proposed Takeover Code Amendments – Key Changes
The Consultation Paper has now been followed by a corresponding response paper which made certain modifications to the initial proposals.
Building Back Better: Future Gazing
What’s next for the hospitality industry post-pandemic?
Building Back Better: Re-examining your proposition
Why hospitality businesses should re-examine their proposition now
Building Back Better: Real Estate and Restructuring
How and why should hospitality businesses re-structure post pandemic?
Charles Russell Speechlys advises Fudco Partnership on sale to Exponent-backed Vibrant Foods
Fudco is a family-owned business selling South Asian ethnic foods in UK and Europe.
UK property market continues to thrive
Amelia Goodwin and Georgina O'Sullivan write for Pharmacy Business on managing employee performance
Why contractors should prioritise performance management of employees as a regular feature of their business strategy.